Veracyte Inc (VCYT)
$50.01 -4.14% Close Oct 30, 2026 Live
Veracyte stock today
Veracyte closed at $50.01 on October 30, 2026, down 4.14% on the day. Over the past year it returned +41.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $3.99 billion.
$30.00$40.00$50.00$60.00
NovJan 2026MarMayJulSep
| Period | VCYT | S&P 500 (SPY) |
|---|---|---|
| 1 month | +8.6% | -0.9% |
| 3 months | -16.3% | +2.1% |
| Year to date | +18.8% | +11.7% |
| 1 year | +41.6% | +12.4% |
| 3 years | +147.3% | +88.5% |
| 5 years | +4.4% | +76.0% |
Key statistics
- Market value
- $3.99B
- P/E (trailing)
- 35.7
- Forward P/E
- 26.0
- Price / sales
- 7.1
- 52-week range
- $30.01 to $60.49
- Next report
- Nov 4, 2026
About Veracyte
Molecular diagnostics company providing cancer screening and classification tests.
Sector: Health Care
More on Veracyte
- Financials: revenue, earnings and segmentsRevenue +16% in the year to Dec 2025
- Valuation: P/E history and peersP/E 35.7
- Returns: what $1,000 became$1,000 ten years ago is $6,641 today
No forecast, no recommendation. This page describes Veracyte Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.